Healio Gastroenterology Current Issue
The following articles appeared in the print edition of Healio Gastroenterology.
Table of Contents
- Concerns, Controversies in Pediatric IBD Persist in Era of Biologics
-
- Top 10 IBD Research Shared at DDW
- Following up on Unsymptomatic Erosive Esophagitis Philip O. Katz, MD
- FDA Clears Molecular Test for Diarrhea-causing Pathogens
- FDA Grants Accelerated Approval to Keytruda for Solid Tumors With Specific Biomarker
- Janssen, Protagonist Enter Agreement for IL-23 IBD Candidate
- Tenapanor Improves Symptoms in IBS-C
- Pediatric IBD Issues are Universal, with Transition Being the Next Step Edward V. Loftus Jr., MD
- New Clinical Guide to Help Manage Pediatric Celiac Disease
-
- Nexvax2 Alters Immune Response to Gluten in Patients With Celiac Disease
- Psychological Factors Impact Pediatric Crohn’s Symptoms, Disability
- Study Finds no Link Between PPIs, Dementia, Alzheimer’s Risk
- Too Much Exercise can Cause Acute, Chronic GI Issues
- Uceris Tablets Induce Remission in Mesalamine-refractory, Mild-to-moderate Ulcerative Colitis
- Crohn’s Patients Treated With Anti-TNFs Have Lower Risk for Death Than Those Treated With Corticosteroids
- IBgard Reduces IBS Symptoms Within 24 Hours
- Linx More Effective Than PPIs for Treating Regurgitation in GERD
-
- Novel Genetic Test Predicts Severity of IBD in Children
- EnteroMedics Acquires Medical Weight Loss Device
- OrphoMed Secures $39 Million to Develop IBS-D Treatment